Renal Insufficiency: all 2,030 studies

Page 4 of 21. Open to participants first (168), then studies with results posted, then the rest; newest registration first within each.

• Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim3)CompletedNCT02058095Phase 1/2Results posted
• Ureteral Stents Versus Percutaneous Nephrostomy for Initial Urinary DrainageCompletedNCT02055430Not applicableResults posted
• PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy VolunteersCompletedNCT02039817Phase 1Results posted
• Pharmacokinetics, Pharmacodynamics, and Safety Study of Ticagrelor in Hemodialysis Patients and Healthy SubjectsCompletedNCT02022748Phase 1Results posted
• Pharmacokinetics of Sugammadex (MK-8616) in Participants With Moderate and Severe Renal Insufficiency (MK-8616-105)CompletedNCT02011490Phase 1Results posted
• A Phase 2 Study of Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) in Patients With End-Stage Kidney Disease on HemodialysisCompletedNCT01999582Phase 2Results posted
• Comparing Everolimus and Sirolimus in Renal Transplant RecipientsCompletedNCT01976390Not applicableResults posted
• Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Systolic Cardiomyopathy (Aim2)CompletedNCT01970176Phase 1/2Results posted
• Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily.CompletedNCT01962922Phase 3Results posted
• Buttonhole Versus Step Ladder Cannulation in High Dose HemodialysisCompletedNCT01962025Not applicableResults posted
• Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal InsufficiencyCompletedNCT01958281Phase 2Results posted
• Pharmacokinetics, Safety and Tolerability of the Combination of BI 207127 and Faldaprevir in Renal Impaired PatientsTerminatedNCT01957657Phase 1Results posted
• Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)CompletedNCT01948986Phase 1Results posted
• IVUS Guidance to Reduce Contrast in Coronary AngioplastyCompletedNCT01947335Phase 4Results posted
• The Pharmacokinetics of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Participants With Renal Insufficiency (MK-5172-050)CompletedNCT01937975Phase 1Results posted
• Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.CompletedNCT01936519Not applicableResults posted
• Improving Communication About Serious IllnessCompletedNCT01933789Not applicableResults posted
• A Study of LY2409021 in Participants With Different Levels of Kidney FunctionCompletedNCT01929109Phase 1Results posted
• Protocolized Diuretic Strategy in Cardiorenal FailureTerminatedNCT01921829Phase 4Results posted
• A Single Ascending Dose Study of Soluble Ferric Pyrophosphate Administered Intravenously in Healthy Volunteers.CompletedNCT01920854Phase 1Results posted
• Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal FunctionCompletedNCT01896297Phase 4Results posted
• Open-label Dose-finding Trial of OPC-41061 in Patients With Chronic Renal Failure Undergoing Peritoneal DialysisCompletedNCT01895322Phase 2Results posted
• Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD PatientsCompletedNCT01894906Phase 1/2Results posted
• Use Of Fragmin In HemodialysisCompletedNCT01879618Phase 3Results posted
• A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or HemodiafiltrationCompletedNCT01876381Phase 2Results posted
• Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal ImpairmentCompletedNCT01857622Phase 3Results posted
• Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower LimbsCompletedNCT01857583Phase 3Results posted
• Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal ImpairmentCompletedNCT01853046Phase 1Results posted
• Study of Romosozumab (AMG 785) Administered to Healthy Participants and Patients With Stage 4 Renal Impairment or Stage 5 Renal Impairment Requiring HemodialysisCompletedNCT01833754Phase 1Results posted
• Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal ImpairmentCompletedNCT01818596Phase 3Results posted
• PF-04634817 Renal Impairment StudyCompletedNCT01791855Phase 1Results posted
• An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate, Severe, or No Renal ImpairmentCompletedNCT01770652Phase 4Results posted
• Pharmacokinetics Of CP-690,550 In Patients With Impaired Renal FunctionCompletedNCT01740362Phase 1Results posted
• Pruritus in Patients With Chronic Kidney DiseaseCompletedNCT01727180Results posted
• Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. ParicalcitolTerminatedNCT01725113Phase 4Results posted
• Study of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal FunctionCompletedNCT01716455Phase 1Results posted
• Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease.CompletedNCT01711853Phase 1Results posted
• A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)CompletedNCT01698775Phase 3Results posted
• Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate SodiumCompletedNCT01680861Phase 3Results posted
• Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney TransplantCompletedNCT01666951Phase 2Results posted
• Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)CompletedNCT01663103Phase 4Results posted
• Assessing the Behavior of Met DR in Subjects With Kidney DysfunctionCompletedNCT01658514Phase 2Results posted
• The Everolimus-Transplant Exit Strategy Trial (E-TEST)TerminatedNCT01636466Phase 3Results posted
• A Phase 3, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME -Anemia Management With EpoetinCompletedNCT01628120Phase 3Results posted
• A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With EpoetinCompletedNCT01628107Phase 3Results posted
• A Single Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Participants With Renal Insufficiency (MK-4618-014)CompletedNCT01628042Phase 1Results posted
• Safety and Tolerability and Efficacy of LCZ696 in Japanese Hypertensive Patients With Renal DysfunctionCompletedNCT01593787Phase 3Results posted
• Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.CompletedNCT01574157Not applicableResults posted
• Multiple Dose Pharmacokinetics of LCZ696 and Its Metabolites in Subjects With Severe Renal Impairment vs. Matched Healthy Subjects With Normal Renal FunctionCompletedNCT01569828Phase 2Results posted
• Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal FunctionCompletedNCT01569815Phase 1Results posted
• A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011)TerminatedNCT01558674Phase 1Results posted
• A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on DialysisCompletedNCT01554982Phase 3Results posted
• Hydroxychloroquine in Cardiovascular Disease in Patients With Chronic Kidney Disease: A Proof of Concept StudyTerminatedNCT01537315Phase 2Results posted
• A Study to Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal ImpairmentCompletedNCT01512849Phase 1Results posted
• Pharmacokinetic Assessment of Single-Dose Odanacatib (MK-0822) in Subjects With Severe Renal Insufficiency (MK-0822-067)CompletedNCT01512667Phase 1Results posted
• Effects of Obesity Surgery on Renal FunctionCompletedNCT01507350Results posted
• Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild HyperkalemiaCompletedNCT01493024Phase 2Results posted
• Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired PatientsCompletedNCT01491113Phase 4Results posted
• A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With EpoetinCompletedNCT01473420Phase 3Results posted
• A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With EpoetinCompletedNCT01473407Phase 3Results posted
• Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)FistulaeCompletedNCT01471041Phase 2/3Results posted
• Fondaparinux in Critically Ill Patients With Renal FailureCompletedNCT01467583Phase 4Results posted
• Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem AdministrationCompletedNCT01467271Results posted
• Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on DialysisCompletedNCT01464931Phase 1Results posted
• The Impact of Nebivolol Versus Metoprolol on Quality of LifeTerminatedNCT01441570Not applicableResults posted
• Does Nesiritide Provide Renal ProtectionCompletedNCT01440881Phase 2Results posted
• Effect of Short Term Aliskiren Treatment in Kidney Transplant PatientsTerminatedNCT01437943Phase 4Results posted
• Pharmacokinetics of Peginterferon Alfa-2b in Participants With Moderate and Severe Renal Impairment (P05655)CompletedNCT01432535Phase 1Results posted
• A Study of Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009)CompletedNCT01407276Phase 1Results posted
• Exercise Intolerance in Renal FailureCompletedNCT01356966Phase 2Results posted
• Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients (CRUISE 2)CompletedNCT01322347Phase 3Results posted
• Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis PatientsCompletedNCT01320202Phase 3Results posted
• Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal ImpairmentCompletedNCT01316055Phase 1Results posted
• Effect of Remote Ischaemic Preconditioning on Renal Function in Patients Undergoing Living Donor Kidney TransplantationCompletedNCT01289548Not applicableResults posted
• The Effect of Loop Diuretics on Severity and Outcome of Acute Kidney InjuryCompletedNCT01275729Not applicableResults posted
• A Single-Dose Study to Investigate the Pharmacokinetics of MK-7655 in Participants With Impaired Renal Function (MK-7655-005)CompletedNCT01275170Phase 1Results posted
• Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid GlandsCompletedNCT01273597Results posted
• Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary ProcedureCompletedNCT01252810Phase 2Results posted
• Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or ParentsCompletedNCT01245374Phase 4Results posted
• Pharmacokinetics of Dabigatran Etexilate (Pradaxa®) During HaemodialysisCompletedNCT01241539Phase 1Results posted
• A Study in Participants With End-Stage Renal DiseaseCompletedNCT01200290Phase 2Results posted
• A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on DialysisCompletedNCT01191255Phase 3Results posted
• Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney TxCompletedNCT01187953Phase 3Results posted
• Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran EtexilateCompletedNCT01184989Phase 4Results posted
• Randomized Trial of 2 Antibody Induction Steroid Avoidance ProtocolsCompletedNCT01172418Phase 4Results posted
• Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal ImpairmentCompletedNCT01164501Phase 3Results posted
• Achieving Medication Safety During Acute Kidney InjuryCompletedNCT01134900Not applicableResults posted
• Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal ImpairmentTerminatedNCT01104662Phase 4Results posted
• The Impact of Pomegranate Extract on Chronic Cardiomyopathy Complicated by Renal Insufficiency (ImPrOVE): a Pilot StudyTerminatedNCT01102140Phase 2Results posted
• A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.CompletedNCT01098539Phase 3Results posted
• Healthy and Renal Impairment Study of Colcrys (Colchicine, USP)CompletedNCT01084278Phase 4Results posted
• Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical PracticeCompletedNCT01083849Results posted
• Paricalcitol Oral Therapy in Predialysis CKD Patients. The Greek ExperienceCompletedNCT01083186Results posted
• Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal ImpairmentCompletedNCT01082640Phase 2Results posted
• Follow-up Patients With End Stage Renal Disease Receiving Zemplar to Prevent and Treat Secondary HyperparathyroidismCompletedNCT01081665Results posted
• Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal FailureCompletedNCT01072682Not applicableResults posted
• An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal ImpairmentCompletedNCT01064414Phase 3Results posted
• Pharmacokinetics of Suvorexant in Participants With Impaired Renal Function (MK-4305-023)(COMPLETED)CompletedNCT01059851Phase 1Results posted
• Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)CompletedNCT01044303Phase 4Results posted
• Safety, Tolerability, and Pharmacokinetic of Single Dose of Pitavastatin 4 mg in Severe Renal Patients Versus Healthy Adult VolunteersCompletedNCT01043094Phase 4Results posted

← Renal Insufficiency overview